In episode 10 of Hims House, Jonathan Stern, Louis Stevens, and Dr. H interview Sekander Amini, a UK-based pharmacist and long-time Hims investor. Sekander shares insights about how his pharmacy mirrors Hims' model by offering premium services like mental health and weight loss medications. He highlights Hims' advantages in compounding medications, simplifying treatment adherence, and leveraging technology for better patient care. The group discusses the healthcare landscape in the UK, touching on public versus private care and the potential growth opportunity for Hims. They also explore Hims' focus on premium experiences, the role of AI in healthcare, and what investors should watch for in the upcoming earnings call. 00:00 Introduction and Sekander Amino Welcome 00:52 Day-to-Day at the Private Pharmacy 03:24 Initial Investment in Hims 03:51 Hims' Price Transparency and Accessibility 05:46 Compounded Medications and Personalized Care 07:07 Premium Experience and Product Evolution 15:59 Comparing UK and US Healthcare Systems 20:53 Opportunities in the UK Market 23:09 Hims' Generic Offerings 23:30 UK Healthcare System Overview 24:19 Hims' Market Potential in the UK 24:48 Compounding Pharmacies in the UK 25:40 Challenges in International Expansion 27:10 Hims' Strategic Focus 34:18 MedMatch and Mental Health 40:14 International Expansion Concerns 44:09 Q3 Earnings Expectations 45:54 Closing Remarks and Farewell